Osteonecrosis of the femoral head — when the blood supply to the top of the thighbone is cut off and the bone tissue dies — typically strikes adults in their 30s to 50s and, left untreated, often progresses to needing a full hip replacement years before most people expect one.

Because so many different treatments are used (medications, decompression surgery, shockwave therapy, hyperbaric oxygen), doctors and patients alike need a clear picture of what actually works, which is why this large analysis matters: it pooled 29 studies covering 2,177 hips and ranked treatments against each other.

Hyperbaric oxygen — especially when combined with core decompression (a minor surgical procedure that relieves pressure inside the bone) — ranked highest for reducing pain and improving hip function and quality-of-life scores. The honest caveat: no treatment in the analysis, including hyperbaric oxygen, was shown to significantly reduce how often patients eventually needed hip replacement, and the authors note some comparisons were based on limited data, so the rankings should be considered preliminary.

Looking at the individual trials behind this pooled analysis, the hyperbaric protocols used for this bone condition were substantial courses, not quick fixes: studies ran 20 to 40 sessions over several weeks, 3 to 6 days a week, at pressures of roughly 2.2 to 2.5 ATA for 82 to 120 minutes per session. That pattern lines up with a broader theme in hyperbaric research on bone healing — conditions involving slow-healing bone tissue tend to need extended, weeks-long courses rather than the shorter session counts sometimes used for acute soft-tissue issues.

The overall message for patients is that hyperbaric oxygen paired with decompression surgery, delivered as a sustained course, is one of the more promising ways to manage pain from early hip osteonecrosis while other treatment decisions are made.

Read Less

This review looked at whether hyperbaric oxygen therapy (HBOT) helps people with muscle and joint pain conditions such as fibromyalgia, pain after knee replacement, and pain after nerve surgery. Across 18 studies (mostly high-quality trials with 671 patients), HBOT was usually given for 60–90 minutes per session over several days or weeks, at mild to moderate pressure levels (1.3 - 2.5 ATA) Overall, HBOT consistently reduced pain and led to modest improvements in function and quality of life in people with fibromyalgia and some postoperative pain conditions, and it sometimes improved markers of inflammation. However, results were mixed for short-term problems like post-exercise muscle soreness and acute ligament injuries. The authors conclude that HBOT may be a helpful add-on treatment for certain chronic pain conditions, but the evidence is still limited and better, more standardized studies are needed before it can be widely recommended <view study> Read Less

This study included a group of fibromyalgia-diagnosed w0men taking a full course of 40 hyperbaric oxygen sessions at 1.45 ATA (90 minutes per session, 5 days per week, for a total of 8 weeks). Follow up results showed significant improvements in pain threshold <view study> Read Less

This study was used to evaluate the effects of low-pressure hyperbaric oxygen therapy (HBOT) on fatigue, pain, endurance and functional capacity, physical performance and cortical excitability when compared with a physical exercise program in women with fibromyalgia. The hyperbaric protocol used was a 2 month course of daily 90 minute sessions (5 days per week for a total of 40 hours) at 1.45 ATA. During this time period, 60 minutes of low intensity exercises, twice weekly (for a total of 16 sessions), was included in the protocol. This group of participants showed improvements in pressure pain threshold, endurance and functional capacity, as well as physical performance. In addition, the HBOT group reported significant improvements in induced fatigue and perceived pain at rest. <view study> Read Less

Complex regional pain syndrome (CRPS) can be a debilitating disorder associated with severe pain and disability characterized by both auto-inflammatory and autoimmune features. This publication was a case report of a patient with long-standing CRPS that had a dramatic response to a course of hyperbaric oxygen therapy (HBOT) and was able to successfully lower their prednisone dosage. Symptoms reemerged a few months later so a second course of hyperbaric therapy was prescribed. Similarly to the first course, the patient improved symptomatically and was able to once again lower the dose prednisone. “This case is unique in that it shows that HBOT can be effective in long-standing CRPS, both initially, and for subsequent flares, and adds to the evidence supporting HBOT as a potential treatment for this condition” <view study> Read Less